Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca M Casey

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
MMWR. Morbidity and Mortality Weekly Report|July 6, 2023
Status of New Vaccine Introduction - Worldwide, 2016-2021Gurpreet Kaur, Rebecca M Casey, Jaymin C Patel, et al.
Vaccine|October 1, 2021
National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learnedRebecca M Casey, Nedghie Adrien, Ousseynou Badiane, et al.
MMWR. Morbidity and Mortality Weekly Report|November 18, 2016
Global Routine Vaccination Coverage, 2015Rebecca M Casey, Laure Dumolard, M Carolina Danovaro-Holliday, et al.
PLOS Global Public Health|March 24, 2023
Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020Reena H Doshi, Rebecca M Casey, Nedghie Adrien, et al.
Vaccine|August 17, 2024
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary reportRebecca M Casey, Marjorie Sserunga Najjengo, Irene Lubega, et al.
The Lancet. Infectious Diseases|February 9, 2024
Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort studyReena H Doshi, Patrick K Mukadi, Rebecca M Casey, et al.
Vaccine|January 9, 2026
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final reportScarlett E Lee, Marjorie Najjengo, Anna Shaum, et al.
The New England Journal of Medicine|February 15, 2018
Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final ReportRebecca M Casey, Jennifer B Harris, Steve Ahuka-Mundeke, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
MMWR. Morbidity and Mortality Weekly Report|July 6, 2023
Status of New Vaccine Introduction - Worldwide, 2016-2021Gurpreet Kaur, Rebecca M Casey, Jaymin C Patel, et al.
Vaccine|October 1, 2021
National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learnedRebecca M Casey, Nedghie Adrien, Ousseynou Badiane, et al.
MMWR. Morbidity and Mortality Weekly Report|November 18, 2016
Global Routine Vaccination Coverage, 2015Rebecca M Casey, Laure Dumolard, M Carolina Danovaro-Holliday, et al.
PLOS Global Public Health|March 24, 2023
Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020Reena H Doshi, Rebecca M Casey, Nedghie Adrien, et al.
Vaccine|August 17, 2024
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary reportRebecca M Casey, Marjorie Sserunga Najjengo, Irene Lubega, et al.
The Lancet. Infectious Diseases|February 9, 2024
Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort studyReena H Doshi, Patrick K Mukadi, Rebecca M Casey, et al.
Vaccine|January 9, 2026
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final reportScarlett E Lee, Marjorie Najjengo, Anna Shaum, et al.
The New England Journal of Medicine|February 15, 2018
Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final ReportRebecca M Casey, Jennifer B Harris, Steve Ahuka-Mundeke, et al.
Pageof 1